All news

Fund Update: 603,275 ABBOTT LABORATORIES (ABT) shares added to COMMERZBANK AKTIENGESELLSCHAFT |FI portfolio

Alpha Vantage · Quiver Quantitative · · AI-summarised by FinFlash

COMMERZBANK AKTIENGESELLSCHAFT /FI has increased its stake in Abbott Laboratories (ABT) by adding 603,275 shares to its portfolio, as per a recent SEC 13F filing for the report period ending September 30, 2026. The article also details other significant institutional investor activities, insider trading, government contracts awarded to ABT, and congressional stock trading involving ABT shares.

Read original source

ABT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.